Human VCAM-1/CD106 Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB8092

Recombinant Monoclonal Antibody.
R&D Systems, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

Flow Cytometry, Western Blot

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 2691A

View all VCAM-1/CD106 Antibodies »

Product Specifications

Immunogen

Chinese Hamster Ovary cell line CHO-derived human VCAM-1/CD106
Phe25-Glu698
Accession # P19320-1

Specificity

Detects human VCAM-1/CD106 in direct ELISAs.

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for Human VCAM-1/CD106 Antibody

Detection of Human VCAM-1/CD106 by Western Blot.

Western blot shows lysates of HUVEC human umbilical vein endothelial cells untreated (-) or treated (+) with 10 ng/mL Recombinant Human TNF-alpha (210-TA) for 24 hours. PVDF membrane was probed with 4 µg/mL of Rabbit Anti-Human VCAM-1/CD106 Monoclonal Antibody (Catalog # MAB8092) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (HAF008). A specific band was detected for VCAM-1/CD106 at approximately 110 kDa (as indicated). GAPDH (MAB5718) is shown as a loading control. This experiment was conducted under reducing conditions and using Western Blot Buffer Group 1.

Detection of VCAM-1/CD106 in Hut78 Human Cell Line by Flow Cytometry.

Hut78 human cutaneous T cell lymphoma cell line was stained with Rabbit Anti-Human VCAM-1/CD106 Monoclonal Antibody (Catalog # MAB8092, filled histogram) or isotype control antibody (MAB1050, open histogram), followed by Phycoerythrin-conjugated Anti-Rabbit IgG Secondary Antibody (F0110). Staining was performed using our Staining Membrane-associated Proteins protocol.

Applications for Human VCAM-1/CD106 Antibody

Application
Recommended Usage

Flow Cytometry

0.25 µg/106 cells
Sample: Hut78 human cutaneous T cell lymphoma cell line

Western Blot

4 µg/mL
Sample: HUVEC human umbilical vein endothelial cells treated Recombinant Human TNF‑ alpha (Catalog # 210-TA)

Formulation, Preparation, and Storage

Purification

Protein A or G purified from cell culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VCAM-1/CD106

VCAM-1, also known as CD106, is an immunoglobulin (Ig)-like adhesion molecule that is mainly expressed in endothelial cells and other cell types including macrophages, dendritic cells, neurons, smooth muscle cells, fibroblasts, and oocytes (1, 2). It plays a critical role in inflammation by recruiting leukocytes to acute and chronic inflammation sites (3, 4). Alternatively-spliced forms are known to occur, but the most common form is a type I transmembrane protein with a 674 aa extracellular domain (ECD) that includes seven C2-type immunoglobulin domains, a 22 aa transmembrane segment, and a 19 amino acid (aa) cytoplasmic tail. Within the ECD, human VCAM-1 shares 75% and 76% aa sequence identity with the mouse and rat VCAM-1, respectively. VCAM-1 binds to leukocyte integrins alpha 4 beta 1 (VLA-4) and alpha 4 beta 7. During the inflammatory adhesion mechanism, activated integrins halt rolling leukocytes and attach them firmly to the vascular endothelium. The VCAM-1:VLA-4/ alpha 4 beta 7 interaction is also thought to be involved in the extravasation of white blood cells through the blood vessel wall to sites of inflammation (5). ELISA techniques have shown that detectable levels of soluble VCAM-1 are present in the biological fluids of apparently normal individuals, but elevated levels of serum VCAM-1 are indicative of future Atrial Fibrillation incident as well as liver disease (6, 7). Tumor cells use overexpression of VCAM-1 as means of escaping immune surveillance (8).

References

  1. Vonderheide, R.H. et al. (1994) J. Cell Biol. 125:215.
  2. Cybulsky, M.I. et al. (1991) Proc. Natl. Acad. Sci. USA 88:7859.
  3. Luster, A.D. et al. (2005) Nat. Immunol. 6:1182.
  4. Osborn, L. et al. (1989) Cell 59:1203
  5. Langer. H.F. et al. 2009. J Cell Mol Med. 13:1211.
  6. Willeit.K. et al. 2017. JAMA Cardiol. 2:516.
  7. Lo Iacono.O. et al. 2008. Liver Int. 28:1129.
  8. Wu.T.C. et al. 2007. Cancer Research. 67:6003

Long Name

Vascular Cell Adhesion Molecule 1

Alternate Names

CD106, VCAM1

Entrez Gene IDs

7412 (Human); 22329 (Mouse)

Gene Symbol

VCAM1

UniProt

P19320-1

Additional VCAM-1/CD106 Products

Product Documents for Human VCAM-1/CD106 Antibody

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Human VCAM-1/CD106 Antibody

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.